Who owns the RED CELL THERAPEUTICS trademark?

The RED CELL THERAPEUTICS trademark is owned by Rubius Therapeutics, Inc..

What class is the RED CELL THERAPEUTICS trademark registered in?

The RED CELL THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RED CELL THERAPEUTICS?

The USPTO serial number for RED CELL THERAPEUTICS is 88807844.

What is the registration number for RED CELL THERAPEUTICS?

RED CELL THERAPEUTICS is registered under USPTO registration number 6532454.

RED

USPTO Trademark Record

REGISTERED

RED CELL THERAPEUTICS

SN 88807844·Reg 6532454·Filed Feb 24, 2020

Owner Rubius Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RED CELL THERAPEUTICS (Serial No. 88807844), Registration No. 6532454, is a registered US trademark filed on Feb 24, 2020 by Rubius Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: October 19, 2027

Mark Intelligence

RED CELL THERAPEUTICS (Reg. #6532454) is a registered US trademark that has been protecting its owner, Rubius Therapeutics, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Feb 24, 2020

SERIAL

88807844

REG#

6532454

REGISTERED

Oct 19, 2021

Owner

Applicant

Rubius Therapeutics, Inc.

Entity

Corporation

State

Address

399 Binney Street, Cambridge, MA, 02139

Country

Attorney

NameChristina M. Licursi

Law firm

CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.

Docket

R07652000501

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210-2206, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 24, 2020

Serial Number88807844

Registration No.6532454

Registration DateOct 19, 2021

Status DateOct 19, 2021

Mark TypeStandard characters

Attorney DocketR07652000501

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 11, 2020

First use in commerce: Nov 11, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

REGISTERED-SUPPLEMENTAL REGISTER

Oct 19, 2021

REGISTERED-SUPPLEMENTAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Sep 15, 2021

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINERS AMENDMENT -WRITTEN

Sep 07, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Sep 07, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 07, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Sep 07, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Sep 07, 2021

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 21, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 20, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 20, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Feb 09, 2021

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Feb 06, 2021

USE AMENDMENT ACCEPTED

NON-FINAL ACTION WRITTEN

Feb 06, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 06, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 06, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

AMENDMENT TO USE PROCESSING COMPLETE

Jan 12, 2021

AMENDMENT TO USE PROCESSING COMPLETE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 20, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS AMENDMENT OF USE RECEIVED

Nov 19, 2020

TEAS AMENDMENT OF USE RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 19, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 19, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

USE AMENDMENT FILED

Nov 19, 2020

USE AMENDMENT FILED

NON-FINAL ACTION WRITTEN

May 20, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 20, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 20, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 13, 2020

ASSIGNED TO EXAMINER

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Mar 21, 2020

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

ASSIGNED TO LIE

Mar 13, 2020

ASSIGNED TO LIE

TEAS VOLUNTARY AMENDMENT RECEIVED

Mar 06, 2020

TEAS VOLUNTARY AMENDMENT RECEIVED

NEW APPLICATION ENTERED

Feb 27, 2020

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 27, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

RED CELL THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Rubius Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christina M. Licursi

Resources

Company